December 1, 2014, Chicago, IL– The Joint Steering Committee of the American College of Radiology (ACR), AdMeTech Foundation and the European Society of Urogenital Radiology (ESUR) released new global clinical imaging guidelines to improve early detection and treatment of prostate cancer. The new guidelines were announced at the meeting of AdMeTech’s I nternational Prostate MRI Working Group (AdMeTech’s Group) held in conjunction with the Annual Meeting of the Radiologic Society of North America (RSNA). The Joint Steering Committee developed Prostate Imaging Reporting and Data System Version 2 (PI-RADSv2) as global guidelines for high quality multi-parametric prostate MRI service. This work has built on the initial PI-RADS standardization, which was recommended by AdMeTech’s Group in 2010 and created by ESUR in 2011. PI-RADSv2 has defined minimum technical requirements for creating images and in coordination with RSNA’s Radiologic Lexicon Committee, set standards for communicating the risk and location of aggressive prostate cancer. These clinical guidelines were established in order to expedite wide-scale transfer of the high quality clinical service from the few leading research centers to the international medical community. Modeled after similar efforts in mammography that transformed breast cancer care, AdMeTech’s Group has brought together global experts in medicine and industry who have been working in cooperation to expedite the advancement, testing, standardization and implementation of prostate MRI since 2007. PI-RADSv2 will become available on ACR and AdMeTech’s websites in December 2014. Read more

Scholarly Article

Editorial

Members, Joint Steering Committee